1.
Thyroid
; 24(8): 1325-6, 2014 Aug.
Artículo
en Inglés
| MEDLINE
| ID: mdl-24521256
Asunto(s)
Antineoplásicos/uso terapéutico , Carcinoma de Células Renales/tratamiento farmacológico , Indoles/uso terapéutico , Yoduro Peroxidasa/antagonistas & inhibidores , Neoplasias Renales/tratamiento farmacológico , Pirroles/uso terapéutico , Carcinoma de Células Renales/sangre , Humanos , Hipotiroidismo/sangre , Yoduro Peroxidasa/metabolismo , Neoplasias Renales/sangre , Percloratos/química , Sunitinib , Pruebas de Función de la Tiroides , Tirotropina/sangre
2.
Thyroid
; 20(3): 243-4, 2010 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-20187779
3.
Best Pract Res Clin Endocrinol Metab
; 23(6): 781-92, 2009 Dec.
Artículo
en Inglés
| MEDLINE
| ID: mdl-19942153
RESUMEN
Food, dietary fibre and espresso coffee interfere with the absorption of levothyroxine. Malabsorptive disorders reported to affect the absorption of levothyroxine include coeliac disease, inflammatory bowel disease, lactose intolerance as well as Helicobacter pylori (H. pylori) infection and atrophic gastritis. Many commonly used drugs, such as bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine.